Investing.com -- Moody's Ratings has affirmed the Baa3 senior unsecured rating and (P)Baa3 senior unsecured shelf rating of American Tower Corporation (NYSE: AMT ), a leading real estate investment ...

The CreditWatch with negative implications reflects S&P Global Ratings’ view of at least a 50% likelihood that they could lower their ratings by up to two notches over the next few weeks to several ...

S&P forecasts a revenue decline of 8% in 2025, with the EBITDA margin dropping to 14% from 15.3% in 2024, due to lower rig ...

S&P expects Neogen’s revenue to decline by 10% in 2026 due to the company’s strategic aim to refine its focus on the higher-margin and growth food safety end market and undertake divestitures. The ...

A notable feature of the $4 trillion “One, Big Beautiful Bill” introduced by House Republicans is the establishment of a ...

Oklo Inc (NYSE: OKLO), a developer of advanced nuclear reactors, reported a narrower-than-expected loss for the first quarter ...

American Eagle anticipates revenue to be around $1.1 billion, marking a decrease of about 5% compared to the same period the ...

His death marked the end of a long-standing debate over his eligibility for baseball’s highest honor, as players on the ineligible list had been barred from Hall of Fame consideration since a rule ...

European Central Bank (ECB) policymaker Francois Villeroy de Galhau indicated in a recent interview that there may be room for another rate cut by the ECB by the summer. The discussion took place with ...

Based on the robust Q1 results, Exelixis raised its full-year 2025 revenue guidance to $2.25-$2.35 billion, up from its previous forecast of $2.15-$2.25 billion. The new guidance surpasses the current ...

GRAIL, Inc. (NASDAQ:GRAL) reported better-than-expected first-quarter results on Monday, but shares fell 16.6% as the company continued to post significant losses despite revenue growth. The ...

The U.S. Food and Drug Administration (FDA) today initiated a process to withdraw concentrated ingestible fluoride prescription drug products for children from the market. Unlike fluoride toothpaste ...